hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy

Published:2022-08 Issue: Volume:236 Page:154004
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Noorolyai Saeed,Baghbani Elham,Rahmani Shima,Shadbad Mahdi Abdoli,Montazami Nooshin,Jigari-Asl Farinaz,Vazirabad Aysan Fallah,Baradaran Behzad

Funder

Tabriz University of Medical Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference35 articles.

1. Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants;Pareja;NPJ Breast Cancer,2016

2. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells;Plummer;Cancer Res.,2013

3. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer;Zaravinos;J. Urol.,2012

4. MicroRNAs in tumor angiogenesis;Wang;Life Sci.,2015

5. Restoration of miR-143 expression could inhibit migration and growth of MDA-MB-468 cells through down-regulating the expression of invasion-related factors;Tavanafar;Biomed. Pharmacother.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression;Journal of Leukocyte Biology;2024-02-07

2. HSA-MIR-34A-5P ENHANCES TEMOZOLOMIDE ANTI-TUMORAL EFFECTS ON GLIOBLASTOMA: IN-SILICO AND IN-VITRO STUDY;EXCLI J;2024

3. Restoration of miR-200c sensitizes breast cancer cells to cytarabine;2023-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3